SER SERINA THERAPEUTICS INC Management Changes 8-K Filing 2024 - Stockholder Approvals Serina Therapeutics' stockholders approved an amendment to increase the shares reserved under the 2024 Equity Incentive Plan by 950,000 shares to a total of 2,675,000 shares, and three directors were elected for a term until the 2027 Annual Meeting.Get access to all SEC 8-K filings of the SERINA THERAPEUTICS INC